Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Oxaliplatin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 71 Stomach Neoplasms 58 Rectal Neoplasms 36 Colonic Neoplasms 29 Pancreatic Neoplasms 25 Esophageal Neoplasms 23 Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 19 Adenocarcinoma 19 Neoplasm Metastasis 14 Cholangiocarcinoma 14 Carcinoma, Non-Small-Cell Lung 12 Adenocarcinoma Of Esophagus 12 Ovarian Neoplasms 10 Biliary Tract Neoplasms 10 Gastrointestinal Neoplasms 8 Gallbladder Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Locally Advanced Rectal Cancer 5 Recurrence 4 Lymphoma 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4 Carcinoma 4 Bile Duct Neoplasms 4 Advanced Solid Tumors 4 Triple Negative Breast Neoplasms 3 Peritoneal Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

Cisplatin 7 Etoposide 6 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Bleomycin 3 Automobiles 3 pralsetinib 2 pembrolizumab 2 etoposide phosphate 2 Sirolimus 2 Paclitaxel 2 Mesna 2 Drug Therapy 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 tozuleristide 1 sodium thiosulfate 1 repotrectinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Vorinostat 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡